Biotech entity
Every one of those 1 sits in a single category, pharma. Bundibugyo ebolavirus is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Congo (Democratic Republic of the Congo) appears in 1 tracked Biotech story from July 25, 2026.
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Bundibugyo ebolavirus is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Congo (Democratic Republic of the Congo) appears in 1 tracked Biotech story from July 25, 2026. The tracked stories average 4 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Congo (Democratic Republic of the Congo). Shared-story counts are live from our verified record — not editorial picks.
The fastest-growing Ebola outbreak in history is driven by the Bundibugyo virus, which lacks any approved vaccine or therapy. With over 2,100 cases and 864 deaths, biopharma companies face a pressing unmet need and a potential market for rapid filovirus countermeasure development.
Source: wral.com · breitbart.com
Congo (Democratic Republic of the Congo) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
